Free Trial

IDEXX Laboratories (IDXX) Earnings Date, Estimates & Call Transcripts

IDEXX Laboratories logo
$535.54 +1.24 (+0.23%)
As of 03:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

IDEXX Laboratories Earnings Summary

IDEXX Laboratories announced Q1 2025 earnings on May 1, 2025, reporting an EPS of $2.96, which beat the consensus estimate of $2.93 by $0.03. Quarterly revenue rose 3.6% year-over-year to $998.43 million, above analyst estimates of $998.25 million. With a trailing EPS of $10.82 and a P/E Ratio of 49.56, IDEXX Laboratories' earnings are expected to grow 13.83% next year, from $11.93 to $13.58 per share.

Upcoming Q2
Earnings Date
Aug. 4Before Market OpensConfirmed
Consensus EPS
(May. 1)
$2.93
Actual EPS
(May. 1)
$2.96 Beat By $0.03
Actual Revenue
(May. 1)
$998.43M

Q1 2025 Earnings Resources

IDXX Upcoming Earnings

IDEXX Laboratories' Q2 2025 earnings is scheduled for Monday, August 4, 2025, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get IDEXX Laboratories Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IDEXX Laboratories and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

IDXX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IDXX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

IDEXX Laboratories Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue Guidance
Q1 20253$2.77$2.96$2.88
Q2 20253$3.00$3.31$3.15
Q3 20253$3.03$3.13$3.10
Q4 20252$2.84$2.91$2.88
FY 2025 11 $11.64 $12.31 $12.00
Q1 20261$3.32$3.32$3.32
Q2 20261$3.44$3.44$3.44
Q3 20261$3.44$3.44$3.44
Q4 20261$3.34$3.34$3.34

IDEXX Laboratories Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/4/2025
(Confirmed)
-------
5/1/2025Q1 2025$2.93$2.96+$0.03$2.96$998.25M$998.43M
10/31/2024Q3 2024$2.69$2.80+$0.11$2.80$980.32M$975.50M
8/6/2024Q2 2024$2.88$2.44 -$0.44$2.44$1.01B$1.00B
5/1/2024Q1 2024$2.68$2.81+$0.13$2.81$965.43M$964.10M
2/5/2024Q4 2023$2.12$2.32+$0.20$2.32$891.88M$901.60M
11/1/2023Q3 2023$2.37$2.53+$0.16$2.53$926.88M$915.53M
8/1/2023Q2 2023$2.43$2.67+$0.24$2.67$927.84M$943.63M

IDEXX Laboratories Earnings - Frequently Asked Questions

IDEXX Laboratories has confirmed that its next quarterly earnings data will be published on Monday, August 4th, 2025. Learn more on IDXX's earnings history.

In the previous quarter, IDEXX Laboratories (NASDAQ:IDXX) reported $2.96 earnings per share (EPS) to beat the analysts' consensus estimate of $2.93 by $0.03. Learn more on analysts' earnings estimate vs. IDXX's actual earnings.

The conference call for IDEXX Laboratories' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for IDEXX Laboratories' latest earnings report can be read online.
Read Transcript

IDEXX Laboratories' earnings report can be found in their filing with the SEC.
View SEC filing

IDEXX Laboratories (NASDAQ:IDXX) has a recorded annual revenue of $3.90 billion.

IDEXX Laboratories (NASDAQ:IDXX) has a recorded net income of $887.87 million. IDXX has generated $10.82 earnings per share over the last four quarters.

IDEXX Laboratories (NASDAQ:IDXX) has a trailing price-to-earnings ratio of 49.20 and a forward price-to-earnings ratio of 44.54. The price/earnings-to-growth ratio is 4.07.

IDEXX Laboratories' earnings are expected to grow from $11.93 per share to $13.58 per share in the next year, which is a 13.83% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:IDXX) was last updated on 8/1/2025 by MarketBeat.com Staff
From Our Partners